Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma

Identifying therapeutic targets for cancer treatment relies on consistent changes within particular types or sub-types of malignancy. The ability to define either consistent changes or sub-types of malignancy is often masked by tumor heterogeneity. To elucidate therapeutic targets in cutaneous squam...

Descripción completa

Detalles Bibliográficos
Autores principales: Watt, S A, Pourreyron, C, Purdie, K, Hogan, C, Cole, C L, Foster, N, Pratt, N, Bourdon, J-C, Appleyard, V, Murray, K, Thompson, A M, Mao, X, Mein, C, Bruckner-Tuderman, L, Evans, A, McGrath, J A, Proby, C M, Foerster, J, Leigh, I M, South, A P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219832/
https://www.ncbi.nlm.nih.gov/pubmed/21602893
http://dx.doi.org/10.1038/onc.2011.180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219832/
https://www.ncbi.nlm.nih.gov/pubmed/21602893
http://dx.doi.org/10.1038/onc.2011.180

Ejemplares similares